Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
WNT signaling underlies the pathogenesis of neuropathic pain in rodents
Yan-Kai Zhang, … , Angela A. Song, Xue-Jun Song
Yan-Kai Zhang, … , Angela A. Song, Xue-Jun Song
Published April 15, 2013
Citation Information: J Clin Invest. 2013;123(5):2268-2286. https://doi.org/10.1172/JCI65364.
View: Text | PDF
Research Article Neuroscience

WNT signaling underlies the pathogenesis of neuropathic pain in rodents

  • Text
  • PDF
Abstract

Treating neuropathic pain is a major clinical challenge, and the underlying mechanisms of neuropathic pain remain elusive. We hypothesized that neuropathic pain–inducing nerve injury may elicit neuronal alterations that recapitulate events that occur during development. Here, we report that WNT signaling, which is important in developmental processes of the nervous system, plays a critical role in neuropathic pain after sciatic nerve injury and bone cancer in rodents. Nerve injury and bone cancer caused a rapid-onset and long-lasting expression of WNTs, as well as activation of WNT/frizzled/β-catenin signaling in the primary sensory neurons, the spinal dorsal horn neurons, and astrocytes. Spinal blockade of WNT signaling pathways inhibited the production and persistence of neuropathic pain and the accompanying neurochemical alterations without affecting normal pain sensitivity and locomotor activity. WNT signaling activation stimulated production of the proinflammatory cytokines IL-18 and TNF-α and regulated the NR2B glutamate receptor and Ca2+-dependent signals through the β-catenin pathway in the spinal cord. These findings indicate a critical mechanism underlying the pathogenesis of neuropathic pain and suggest that targeting the WNT signaling pathway may be an effective approach for treating neuropathic pain, including bone cancer pain.

Authors

Yan-Kai Zhang, Zhi-Jiang Huang, Su Liu, Yue-Peng Liu, Angela A. Song, Xue-Jun Song

×

Figure 12

WNT/β-catenin signal activation mediates the production of TNF-a, but not IL-1b, in rat SC after CCI.

Options: View larger image (or click on image) Download as PowerPoint
WNT/β-catenin signal activation mediates the production of TNF-a, but no...
(A) qRT-PCR showing increased mRNA levels of Tnfa and Il1b at 1 (CCI 1 d) and 7 (CCI 7 d) days after CCI (n = 3). (B) Western blot showing time courses for the expression of TNF-a and IL-1b (n = 3). (C) Blocking the WNT/β-catenin pathway suppresses CCI-induced upregulation of TNF-a, but not IL-1b. Each of the drugs (Fz-8/Fc, 4 μg; IWR, 5 μM; and Nsm, 1 mM) was given (i.t., in a volume of 20 μl) daily on postoperative days 5, 6, and 7. Tissues were collected 4 hours after the last i.t. administration (n = 4). (D) WNT agonist (40 μM, i.t.) activates TNF-a, but not IL-1b (n = 4). GAPDH in C and D was from the same samples in Figure 11, C and D. One-way ANOVA (A–D) with an individual Student’s t test (C). *P < 0.05, **P < 0.01 versus naive and sham (A–C) or DMSO (1%) (D). ##P < 0.01 versus CCI (C). (E and F) ChIP-PCR assay showing that an anti–β-catenin antibody precipitated chromatin DNA containing a Tnfa (E), but not an Il1b (F) promoter sequence gene. Schematic representation of 3 potential TCF-binding sites in the promoter region of Tnfa (E) and Il1b (F) (top). PCR analyses of DNA pulled down by IgG (negative control) or anti–β-catenin (bottom). Input samples were used as a positive control.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts